These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7425574)

  • 1. Muscle metals in motor neuron disease.
    Pierce-Ruhland R; Patten BM
    Ann Neurol; 1980 Aug; 8(2):193-5. PubMed ID: 7425574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metals in spinal cord tissue of patients dying of motor neuron disease.
    Kurlander HM; Patten BM
    Ann Neurol; 1979 Jul; 6(1):21-4. PubMed ID: 507754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat study of antecedent events in motor neuron disease.
    Pierce-Ruhland R; Patten BM
    Ann Clin Res; 1981 Apr; 13(2):102-7. PubMed ID: 7235610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.
    Vucic S; Kiernan MC
    Brain; 2006 Sep; 129(Pt 9):2436-46. PubMed ID: 16835248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease.
    Josephs KA; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW
    Arch Neurol; 2006 Apr; 63(4):506-12. PubMed ID: 16606762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of aluminium in sporadic motor neuron disease.
    Sood K; Nag D; Chandra SV
    Indian J Med Res; 1990 Feb; 92():9-12. PubMed ID: 2347614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study.
    Stephens B; Guiloff RJ; Navarrete R; Newman P; Nikhar N; Lewis P
    J Neurol Sci; 2006 May; 244(1-2):41-58. PubMed ID: 16487542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal inclusions in sporadic motor neuron disease are negative for alpha-synuclein.
    Sasaki S; Komori T; Iwata M
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):15-9. PubMed ID: 16406315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of FKBP12 and ryanodine receptors (RyRs) in the spinal cord of MND patients.
    Kihira T; Utunomiya H; Kondo T
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Jun; 6(2):94-9. PubMed ID: 16036432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor neuron disease: a primary disorder of corticomotoneurons?
    Pamphlett R; Kril J; Hng TM
    Muscle Nerve; 1995 Mar; 18(3):314-8. PubMed ID: 7870109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical selective vulnerability in motor neuron disease: a morphometric study.
    Maekawa S; Al-Sarraj S; Kibble M; Landau S; Parnavelas J; Cotter D; Everall I; Leigh PN
    Brain; 2004 Jun; 127(Pt 6):1237-51. PubMed ID: 15130949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heavy metals in locus ceruleus and motor neurons in motor neuron disease.
    Pamphlett R; Kum Jew S
    Acta Neuropathol Commun; 2013 Dec; 1():81. PubMed ID: 24330485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for pathological involvement of the spinal cord in motor neuron disease-inclusion dementia.
    Holton JL; Révész T; Crooks R; Scaravilli F
    Acta Neuropathol; 2002 Mar; 103(3):221-7. PubMed ID: 11907801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Critical analysis of the results of muscle biopsies and of the methods used in 889 cases of neuromuscular disorders].
    Deruaz JP; Janzer RC
    Schweiz Rundsch Med Prax; 1994 Jan; 83(4):101-5. PubMed ID: 8115761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease.
    Gorell JM; Johnson CC; Rybicki BA; Peterson EL; Kortsha GX; Brown GG; Richardson RJ
    Neurotoxicology; 1999; 20(2-3):239-47. PubMed ID: 10385887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor neuron disease in Australia (State of New South Wales).
    Lance JW; Enis J; Duckworth JW
    Clin Exp Neurol; 1977; 14():42-50. PubMed ID: 616608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electromyography (EMG) accuracy compared to muscle biopsy in childhood.
    Rabie M; Jossiphov J; Nevo Y
    J Child Neurol; 2007 Jul; 22(7):803-8. PubMed ID: 17715269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and electromyographic observations on the diagnosis of motor neuron diseases (MND)].
    Fuzzi O; Fardin P; Zanchin G
    Riv Patol Nerv Ment; 1982; 103(1):1-11. PubMed ID: 7170583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pronostic factors and survival in motor neuron disease].
    Larrode-Pellicer P; Alberti-González O; Iñiguez-Martínez C; Santos Lasaosa S; Pérez-Lázaro C; López del Val LJ
    Neurologia; 2007; 22(6):362-7. PubMed ID: 17610164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.